GSK braced for low sales of flu drug
Health / Medicine Related News
The UK based pharmaceutical company is bracing itself for sales on its pandemic flu vaccines to be as low as three-quarters of forecast levels of £2bn, as a growing number of European countries renege on existing contracts
Source: FT.com - Pharmaceuticals